TY - JOUR
T1 - Prostate cancer early detection, version 2.2015
T2 - Clinical practice guidelines in oncology
AU - Carroll, Peter R.
AU - Parsons, J. Kellogg
AU - Andriole, Gerald
AU - Bahnson, Robert R.
AU - Barocas, Daniel A.
AU - Castle, Erik P.
AU - Catalona, William J.
AU - Dahl, Douglas M.
AU - Davis, John W.
AU - Epstein, Jonathan I.
AU - Etzioni, Ruth B.
AU - Farrington, Thomas
AU - Hemstreet, George P.
AU - Kawachi, Mark H.
AU - Lange, Paul H.
AU - Loughlin, Kevin R.
AU - Lowrance, William
AU - Maroni, Paul
AU - Mohler, James
AU - Morgan, Todd M.
AU - Nadler, Robert B.
AU - Poch, Michael
AU - Scales, Chuck
AU - Shaneyfelt, Terrence M.
AU - Smaldone, Marc C.
AU - Sonn, Geoffrey
AU - Sprenke, Preston
AU - Vickers, Andrew J.
AU - Wake, Robert
AU - Shead, Dorothy A.
AU - Freedman-Cass, Deborah
N1 - Publisher Copyright:
© National Comprehensive Cancer Network, Inc. 2015, All rights reserved.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.
AB - Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.
UR - http://www.scopus.com/inward/record.url?scp=84983122741&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2015.0181
DO - 10.6004/jnccn.2015.0181
M3 - Article
C2 - 26656522
AN - SCOPUS:84983122741
SN - 1540-1405
VL - 13
SP - 1534
EP - 1561
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 12
ER -